To the Editor.— The Special Communication by Monsanto consultants Daughaday and Barbano1 and the accompanying editorial2 are misleading and scientifically flawed for reasons that include the following:The claim that the Food and Drug Administration (FDA) "ensures that all new products used by dairy farmers are safe"1 is controverted by extensive congressional investigations, which concluded that regulation of animal drugs is in disarray and characterized by denial and cover-ups.3 Monsanto and the FDA are now under investigation by the US Inspector General for suppression and manipulation of "animal health test data—in efforts to approve commercial use" of rbST.4The use of rbST is referred to as "supplementation,"1 ignoring the FDA admission that rbST is up to "3% different in molecular structure" from endogenous bST, containing up to nine additional amino acids. Substitution of a single amino acid can profoundly alter a protein molecule's biological activity.4The claim that cows are not
The claim that the Food and Drug Administration (FDA) "ensures that all new products used by dairy farmers are safe"1 is controverted by extensive congressional investigations, which concluded that regulation of animal drugs is in disarray and characterized by denial and cover-ups.3 Monsanto and the FDA are now under investigation by the US Inspector General for suppression and manipulation of "animal health test data—in efforts to approve commercial use" of rbST.4
The use of rbST is referred to as "supplementation,"1 ignoring the FDA admission that rbST is up to "3% different in molecular structure" from endogenous bST, containing up to nine additional amino acids. Substitution of a single amino acid can profoundly alter a protein molecule's biological activity.4
The claim that cows are not
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.